Join to view full profile
1100 Reid PkwySte 105Richmond, IN 47374
Phone+1 765-983-3000
Fax+1 765-935-8774
Dr. Modi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1997 - 2000
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1994 - 1997
Baroda Medical CollegeClass of 1991
Certifications & Licensure
IL State Medical License 1996 - 2029
AZ State Medical License 2025 - 2027
CA State Medical License 2025 - 2027
CO State Medical License 2026 - 2027
IN State Medical License 2024 - 2027
OR State Medical License 2025 - 2027
MN State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2012-2017
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2012-2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
- Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23
- Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Publications & Presentations
PubMed
- 92 citationsAn open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancerWalter M. Stadler, David J. Vaughn, Guru Sonpavde, Nicholas J. Vogelzang, Scott T. Tagawa
Cancer. 2014-04-01 - 39 citationsDasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II ConsortiumManish R. Sharma, Kristen Wroblewski, Blase N. Polite, James A. Knost, James A. Wallace
Investigational New Drugs. 2012-06-01 - 163 citationsTemsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II ConsortiumSonali M. Smith, Koen van Besien, Theodore Karrison, Janet Dancey, Peter McLaughlin
Journal of Clinical Oncology. 2010-11-01
Journal Articles
- Walter M Stadler, David J Vaughn, Guru Sonpavde, Nicholas J Vogelzang, Scott T Tagawa, Daniel P Petrylak, Peter Rosen, Chia-Chi Lin, John Mahoney, Sanjiv Modi, Peter L..., Cancer, 1/11/2014
- Manish R Sharma, Kristen Wroblewski, Blase N Polite, James A Knost, James A Wallace, Sanjiv Modi, Bethany G Sleckman, David Taber, Everett E Vokes, Walter M Stadler, H..., Invest New Drugs, 1/1/2012
- Sonali M. Smith, Koen van Besien, Theodore Karrison, Janet Dancey, Peter McLaughlin, Anas Younes, Scott Smith, Patrick Stiff, Eric Lester, Sanjiv Modi, L. Austin Doyle..., Journal of Clinical Oncology, 1/1/2010
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:












